Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study

Nom du journal : Clin Colorectal Cancer

Année : 2005

Volume : 5

Page de départ : 101

Page de fin : 107

Auteurs: Twelves CJ, Butts CA, Cassidy J, Conroy T, de Braud F, Diaz-Rubio E, Tabernero JM, Schöffski P, Figer A, Brunet R, Grossmann J, Sobrero AF, Van Cutsem EJ, on behalf of the XELOX investigators, on behalf of the XELOX investigators,